[1]
|
McGuire, S. (2016) World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Advances in Nutrition: An International Review Journal, 7, 418-419. https://doi.org/10.3945/an.116.012211
|
[2]
|
Chen, W., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132.
https://doi.org/10.3322/caac.21338
|
[3]
|
de Villiers, E.M., Fauquet, C., Broker, T.R., Bernard, H.-U. and Hausen, H. (2004) Classification of Papillomaviruses. Virology, 324, 17-27. https://doi.org/10.1016/j.virol.2004.03.033
|
[4]
|
Satterwhite, C.L., et al. (2013) Sexually Transmitted Infections among US Women and Men: Prevalence and Incidence Estimates, 2008. Sexually Transmitted Diseases, 40, 187-193.
|
[5]
|
Myers, E.R., McCrory, D.C., Nanda, K., Bastian, L. and Matchar, D.B. (2000) Mathematical Model for the Natural History of Human Papillomavirus Infection and Cervical Carcinogenesis. American Journal of Epidemiology, 151, 1158-1171.
|
[6]
|
Muñoz, N., et al. (2003) Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. The New England Journal of Medicine, 348, 518-527.
|
[7]
|
Dürst, M., Gissmann, L., Ikenberg, H. and zur Hausen, H. (1983) A Papillomavirus DNA from a Cervical Carcinoma and Its Prevalence in Cancer Biopsy Samples from Different Geographic Regions. Proceedings of the National Academy of Sciences of the United States of America, 80, 3812-3815.
|
[8]
|
Hartwig, S., St Guily, J.L., Dominiak-Felden, G., Alemany, L. and de Sanjosé S. (2017) Estimation of the Overall Burden of Cancers, Precancerous Lesions, and Genital Warts Attributable to 9-Valent HPV Vaccine Types in Women and Men in Europe. Infectious Agents and Cancer, 12, 19.
|
[9]
|
de Martel, C., Plummer, M., Vignat, J. and Franceschi, S. (2017) Worldwide Burden of Cancer Attributable to HPV by Site, Country and HPV Type. International Journal of Cancer, 141, 664-670. https://doi.org/10.1002/ijc.30716
|
[10]
|
Chen, W., et al. (2009) Human Papillomavirus Type-Distribution in Cervical Cancer in China: The Importance of HPV 16 and 18. Cancer Causes & Control, 20, 1705-1713.
|
[11]
|
Chen, W., et al. (2016) The Variable Clinicopathological Categories and Role of Human Papillomavirus in Cervical Adenocarcinoma: A Hospital Based Nation-Wide Multi-Center Retrospective Study across China. International Journal of Cancer, 139, 2687-2697.
|
[12]
|
Mesri, E.A., Feitelson, M.A. and Munger, K. (2014) Human Viral Oncogenesis: A Cancer Hallmarks Analysis. Cell Host & Microbe, 15, 266-282.
|
[13]
|
余艳琴, 乔友林. 中国HPV预防性疫苗防治宫颈癌的应用前景[J]. 肿瘤预防与治疗, 2018, 31(4): 237-241.
|
[14]
|
Committee on Practice Bulletins—Gynecology (2012) ACOG Practice Bulletin Number 131: Screening for Cervical Cancer. Obstetrics and Gynecology, 120, 1222-1238.
|
[15]
|
Stanley, M., Lowy, D.R. and Frazer, I. (2006) Chapter 12: Prophylactic HPV Vaccines: Underlying Mechanisms. Vaccine, 24, S106-S113. https://doi.org/10.1016/j.vaccine.2006.05.110
|
[16]
|
Van Damme, P., et al. (2016) A Phase III Clinical Study to Compare the Immunogenicity and Safety of the 9-Valent and Quadrivalent HPV Vaccines in Men. Vaccine, 34, 4205-4212. https://doi.org/10.1016/j.vaccine.2016.06.056
|
[17]
|
Hancock, G., Hellner, K. and Dorrell, L. (2017) Therapeutic HPV Vaccines. Best Practice & Research Clinical Obstetrics & Gynaecology, 47, 59-72. https://doi.org/10.1016/j.bpobgyn.2017.09.008
|
[18]
|
Schiller, J.T., Castellsagué, X. and Garland, S.M. (2012) A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines. Vaccine, 30, F123-F138. https://doi.org/10.1016/j.vaccine.2012.04.108
|
[19]
|
Emiko, P., et al. (2015) Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on immunization Practices. Mmwr Morbidity & Mortality Weekly Report, 64, 300-304.
|
[20]
|
Pitisuttithum, P., Velicer, C. and Luxembourg, A. (2015) 9-Valent HPV Vaccine for Cancers, Pre-Cancers and Genital Warts Related to HPV. Expert Review of Vaccines, 14, 1405-1419. https://doi.org/10.1586/14760584.2015.1089174
|
[21]
|
Cuschieri, K., et al. (2015) Influence of HPV Type on Prognosis in Patients Diagnosed with Invasive Cervical Cancer. International Journal of Cancer, 135, 2721-2726. https://doi.org/10.1002/ijc.28902
|
[22]
|
罗雅娟, 王丹丹, 杨清. HPV致女性生殖道疾病及HPV疫苗现况[J]. 国际生殖健康/计划生育杂志, 2019, 38(3): 244-248.
|
[23]
|
Han, J.J., Beltran, T.H., Song, J.W., Klaric, J. and Choi, Y.S. (2017) Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014. JAMA Oncology, 3, 810-816.
|
[24]
|
Lu, P.J., et al. (2019) Association of Provider Recommendation and Human Papillomavirus Vaccination Initiation among Male Adolescents Aged 13-17 Years-United States. The Journal of Pediatrics, 206, 33-41.e1.
|